SCM
AGTC

Stevens Capital Management’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Stevens Capital Management’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-10,483
Closed -$148K – 1204
2016
Q2 		$148K Buy
+10,483
New +$164K 0.01% 809

Other funds holding AGTC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Stevens Capital Management's AGTC Position: Q3 2016 in Review

Stevens Capital Management sold out of Applied Genetic Technologies Corporation (AGTC) in Q3 2016, closing a stake of 10,483 shares — an estimated $148K sold.

Stevens Capital Management first reported a position in AGTC in Q2 2016 and held it in 1 quarter. The position peaked at $148K in Q2 2016. 95 funds tracked by Wall St. Rank hold AGTC as of Q3 2016.

  • Stevens Capital Management reported no remaining Applied Genetic Technologies Corporation position as of Q3 2016 after selling out during the quarter.
  • Stevens Capital Management sold 10,483 Applied Genetic Technologies Corporation shares in Q3 2016, an estimated $148K.
  • Stevens Capital Management first reported a position in Applied Genetic Technologies Corporation in Q2 2016 and held it in 1 quarter.
  • Stevens Capital Management's Applied Genetic Technologies Corporation position peaked at $148K in Q2 2016.
  • 95 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q3 2016.

Based on Stevens Capital Management's 13F filing for Q3 2016, filed 8 Nov 2016.